Regenstrief research scientist Noll Campbell, PharmD, M.S., spoke about a common class of drugs and how it affects the brain on an Indianapolis radio show.

Dr. Campbell was a guest on Caregiver Crossing, which airs every Saturday on 93.1 WIBC. Dr. Campbell addressed the topic of anticholinergics and their potential link to Alzheimer’s and dementia. Anticholinergics are a common class of drug that includes some allergy medications, sleeping pills and many more common medicines.

Dr. Campbell recently received a $3.3 million grant from the National Institute on Aging to conduct the first clinical trial designed to determine if stopping these medications results in sustained improvements in cognition.

Listen to his discussion with the Caregiver Crossing hosts and his advice for people who are taking these medications.

Segment 1

 

Segment 2

Click here for more information on Caregiver Crossing.

Related News

Sep 20, 2019 • Executive Update, News
A Message from Peter Embí, CEO: International stage promotes collaboration, relationships
The exchange of ideas is vital to advancing healthcare around the globe. Opening dialogues, establishing relationships and partnerships, and sharing expertise help move research forward and promote discovery. This is an environment in which we at Regenstrief Institute excel. Professional meetings offer exceptional and important opportunities to initiate formal and informal, long-term and brief connections.…
Continue Reading >
Sep 18, 2019 • News
Regenstrief research manager presenting at national meeting for research professionals
Regenstrief Institute Senior Research Manager Laura Holtz, M.S., will be a plenary presenter at the annual conference of the Society of Clinical Research Associates (SOCRA). Holtz is a national leader in research and is dedicated to educating other research professionals. Holtz will speak to conference attendees about strategies to include vulnerable subjects with cognitive impairment…
Continue Reading >